Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-13 6:04 pm Sale |
2022-12-31 | 13G | Mersana Therapeutics, Inc. MRSN |
Rho Ventures V L.P. | 604,213 0.600% |
-726,974 (-54.61%) |
Filing History |
| 2023-02-13 12:57 pm Sale |
2022-12-31 | 13G | NGM Biopharmaceuticals, Inc. NGM |
Rho Ventures V L.P. | 430,783 0.500% |
-3,372,487 (-88.67%) |
Filing History |
| 2021-02-16 2:53 pm Purchase |
2020-12-31 | 13G | NGM Biopharmaceuticals, Inc. NGM |
Rho Ventures V L.P. | 3,803,270 5.500% |
12,604 (+0.33%) |
Filing History |
| 2021-02-12 5:25 pm Purchase |
2020-12-31 | 13G | NGM Biopharmaceuticals, Inc. NGM |
Rho Ventures V L.P. | 3,790,666 5.500% |
6,000 (+0.16%) |
Filing History |